Drug Trials and Isolation

David discusses the intriguing link between tachykinins and aggression in individuals with borderline personality disorder. He highlights the missed opportunity for a clinical trial during the COVID pandemic, where the effects of social isolation on drug efficacy could have been explored. Despite the potential for these drugs to alleviate stress-induced anxiety and aggression, economic constraints hinder further investigation.